RU2021137547A - Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи - Google Patents

Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи Download PDF

Info

Publication number
RU2021137547A
RU2021137547A RU2021137547A RU2021137547A RU2021137547A RU 2021137547 A RU2021137547 A RU 2021137547A RU 2021137547 A RU2021137547 A RU 2021137547A RU 2021137547 A RU2021137547 A RU 2021137547A RU 2021137547 A RU2021137547 A RU 2021137547A
Authority
RU
Russia
Prior art keywords
amino acid
acid residue
heavy chains
human animals
transgenic non
Prior art date
Application number
RU2021137547A
Other languages
English (en)
Inventor
Вим ВАН СХОТЕН
Натан ТРИНКЛАЙН
Шелли ФОРС-АЛЬДРЕД
Марианна БРЮГГЕМАНН
Майкл ОСБОРН
Original Assignee
Тенеобио, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тенеобио, Инк. filed Critical Тенеобио, Инк.
Publication of RU2021137547A publication Critical patent/RU2021137547A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/522—CH1 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Claims (1)

  1. Выделенное человеческое или химерное антитело, содержащее только тяжелые цепи (HCAb), содержащее вариабельный домен (VH) тяжелой цепи, содержащий определяющие комплементарность области (CDR) и каркасные области (FR), имеющее аффинность связывания с антигеном-мишенью в отсутствии легкой цепи антитела, причем в указанном VH домене нативный аминокислотный остаток в первой позиции четвертой каркасной области (FR4) указанного HCAb замещен другим аминокислотным остатком, который способен нарушать целостность экспонированного на поверхности гидрофобного пятна, содержащего нативный аминокислотный остаток или связанного с нативным аминокислотным остатком в этой позиции.
RU2021137547A 2016-08-24 2017-08-22 Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи RU2021137547A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662379075P 2016-08-24 2016-08-24
US62/379,075 2016-08-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2019108240A Division RU2762835C2 (ru) 2016-08-24 2017-08-22 Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи

Publications (1)

Publication Number Publication Date
RU2021137547A true RU2021137547A (ru) 2022-01-11

Family

ID=59772725

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2021137547A RU2021137547A (ru) 2016-08-24 2017-08-22 Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи
RU2019108240A RU2762835C2 (ru) 2016-08-24 2017-08-22 Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2019108240A RU2762835C2 (ru) 2016-08-24 2017-08-22 Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи

Country Status (11)

Country Link
US (1) US20190225671A1 (ru)
EP (1) EP3503722A1 (ru)
JP (2) JP7229153B2 (ru)
KR (2) KR20190052006A (ru)
CN (1) CN109862784A (ru)
AU (1) AU2017316604A1 (ru)
BR (1) BR112019003547A2 (ru)
CA (1) CA3034706A1 (ru)
MX (1) MX2019002256A (ru)
RU (2) RU2021137547A (ru)
WO (1) WO2018039180A1 (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017281034B2 (en) 2016-06-21 2024-03-14 Teneobio, Inc. CD3 binding antibodies
KR102507537B1 (ko) 2016-09-14 2023-03-08 테네오원, 인코포레이티드 Cd3 결합 항체
AU2017382251A1 (en) 2016-12-21 2019-07-11 Teneobio, Inc. Anti-BCMA heavy chain-only antibodies
KR20200018498A (ko) * 2017-06-20 2020-02-19 테네오바이오, 인코포레이티드 항-bcma 중쇄-단독 항체
EP3642236A1 (en) 2017-06-20 2020-04-29 TeneoOne, Inc. Anti-bcma heavy chain-only antibodies
AU2018392088A1 (en) * 2017-12-22 2020-08-13 Teneobio, Inc. Heavy chain antibodies binding to CD22
KR20210032311A (ko) * 2018-07-20 2021-03-24 테네오바이오, 인코포레이티드 Cd19에 결합하는 중쇄 항체
GB2576914A (en) 2018-09-06 2020-03-11 Kymab Ltd Antigen-binding molecules comprising unpaired variable domains produced in mammals
BR112021000173A2 (pt) 2018-10-26 2021-05-04 Teneobio, Inc. anticorpos de cadeia pesada com ligação a cd38
MX2021015337A (es) 2019-06-14 2022-01-18 Teneobio Inc Anticuerpos multiespecificos de cadena pesada que se unen a cd22 y cd3.
BR112022003735A2 (pt) * 2019-08-29 2022-06-21 Nat Institute For Biotechnology In The Negev Ltd Anticorpo de domínio único para alvejar antígeno de membrana específico da próstata (psma)
CA3158579A1 (en) 2019-12-18 2021-06-24 Pranjali DALVI Heavy chain antibodies binding to cd38
BR112022027101A2 (pt) 2020-06-30 2023-03-14 Teneobio Inc Anticorpos multiespecíficos que se ligam a bcma
EP4211155A1 (en) 2020-09-11 2023-07-19 Regeneron Pharmaceuticals, Inc. Identification and production of antigen-specific antibodies
TW202233684A (zh) 2020-11-18 2022-09-01 美商泰尼歐生物公司 結合於葉酸受體α之重鏈抗體
CN116848254A (zh) 2020-12-16 2023-10-03 瑞泽恩制药公司 表达人源化Fcα受体的小鼠
JP2024507540A (ja) 2021-02-25 2024-02-20 テネオバイオ， インコーポレイテッド 抗ｐｓｍａ抗体及びｃａｒ－ｔ構造
MX2023009882A (es) 2021-02-26 2023-08-30 Teneobio Inc Anticuerpos anti-muc1-c y estructuras car-t.
TW202304994A (zh) 2021-04-02 2023-02-01 美商泰尼歐生物公司 促效性抗ｉｌ－２ｒ抗體及使用方法
JP2024514107A (ja) 2021-04-06 2024-03-28 テネオバイオ， インコーポレイテッド 抗ｃｄ１９抗体及びｃａｒ－ｔ構造体
KR20230171952A (ko) 2021-04-16 2023-12-21 테네오바이오, 인코포레이티드 항-cd20 항체 및 car-t 구조
WO2022271987A1 (en) 2021-06-23 2022-12-29 TeneoFour, Inc. Anti-cd38 antibodies and epitopes of same
WO2023004197A1 (en) 2021-07-23 2023-01-26 Teneoten, Inc. Heavy chain antibodies binding to hepatitis b surface antigen
CA3234966A1 (en) 2021-10-14 2023-04-20 Teneobio, Inc. Mesothelin binding proteins and uses thereof
WO2024026358A1 (en) 2022-07-27 2024-02-01 Teneobio, Inc. Mesothelin binding proteins and uses thereof
WO2024049684A1 (en) 2022-08-30 2024-03-07 Amgen Inc. Live cell profiling assay
WO2024077044A1 (en) 2022-10-05 2024-04-11 Amgen Inc. Combination therapies comprising t-cell redirecting therapies and agonistic anti-il-2r antibodies or fragments thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0110029D0 (en) * 2001-04-24 2001-06-13 Grosveld Frank Transgenic animal
GB0115256D0 (en) 2001-06-21 2001-08-15 Babraham Inst Mouse light chain locus
JP2005289809A (ja) * 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
NZ540771A (en) 2003-01-10 2009-05-31 Ablynx Nv Recombinant VHH single domain antibody from camelidae against von willebrand factor (vWF) or against collagen
SI1745075T1 (sl) 2004-04-21 2013-07-31 The Brigham And Women's Hospital, Inc. Poli-N-acetilglukozamin (PNAG/dPNAG) vezavni peptidi in postopki za njihovo uporabo
EP1864998B2 (en) * 2004-07-22 2022-06-22 Erasmus University Medical Center Rotterdam Binding molecules
WO2008074839A2 (en) * 2006-12-19 2008-06-26 Ablynx N.V. Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
US20100122358A1 (en) 2008-06-06 2010-05-13 Crescendo Biologics Limited H-Chain-only antibodies
GB0905023D0 (en) * 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей

Also Published As

Publication number Publication date
BR112019003547A2 (pt) 2019-05-28
RU2762835C2 (ru) 2021-12-23
JP7229153B2 (ja) 2023-02-27
US20190225671A1 (en) 2019-07-25
RU2019108240A3 (ru) 2020-10-16
KR20190052006A (ko) 2019-05-15
CA3034706A1 (en) 2018-03-01
KR20230039773A (ko) 2023-03-21
JP2021183648A (ja) 2021-12-02
AU2017316604A1 (en) 2019-04-11
JP2019528295A (ja) 2019-10-10
EP3503722A1 (en) 2019-07-03
CN109862784A (zh) 2019-06-07
MX2019002256A (es) 2019-10-09
WO2018039180A1 (en) 2018-03-01
RU2019108240A (ru) 2020-10-02

Similar Documents

Publication Publication Date Title
RU2021137547A (ru) Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи
HRP20210170T1 (hr) Protutijela protiv b7-h3 i konjugati protutijela s lijekom
CO2019012356A2 (es) Formulaciones estables de anticuerpos anti-tigit solos y en combinación con anticuerpos receptores de muerte programada 1 (pd-1) y métodos para su uso
NZ739721A (en) Antigen binding constructs to target molecules
JP2019528240A5 (ru)
CR20170026A (es) Anticuerpos anti-tau humanizados
ES2523194T3 (es) Anticuerpo monoclonal humano específico para cada tumor
EA201991577A1 (ru) Новые антитела против рецептора трансферрина человека, способные преодолевать гематоэнцефалический барьер
DK3883966T3 (da) Humaniseret anti-human-pd-1-antistof
MX2019005117A (es) Anticuerpos dirigidos contra la muerte programada 1 (pd-1).
RU2531523C3 (ru) Стабильные и растворимые антитела, ингибирующие vegf
RS54271B1 (en) HUMAN MONOCLONIC ANTIBODIES FOR LIGAND PROGRAMMED DEATH 1 (PD-L1)
RS53760B1 (en) HUMAN ANTIBODIES RELATING TO MESOTELINE AND THEIR USES
JOP20180042A1 (ar) نطاقات ربط مولد ضد متوافقة مع البشر وطرق الاستخدام
DK3389699T3 (da) Kimæriske og humaniserede anti-humane CTLA4-monoklonale antistoffer og anvendelser deraf
NZ628528A (en) Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
MX2015012540A (es) Ratón de cadena ligera común.
CY1117203T1 (el) Διαλυτα «βαριας αλυσιδας-mono» αντισωματα
WO2010027488A3 (en) Monoclonal antibodies
SI2883449T1 (en) Light-chain modified antibodies with histidine and genetically modified rodents for their production
SG194466A1 (en) Non-human animals expressing antibodies having a common light chain
EA201990672A1 (ru) Антитела, специфически связывающиеся с pd-1, и их функциональные фрагменты
RS53258B (en) HUMAN ANTIBODIES AGAINST HEPATITIS C (HCV) VIRUS AND USE
MA44091A (fr) Animaux non humains présentant un locus de chaîne légère d'immunoglobuline lambda modifié
HRP20230411T1 (hr) Dvostruko ciljanje